<DOC>
	<DOC>NCT02487199</DOC>
	<brief_summary>This study evaluates the efficacy and safety of ombitasvir/paritaprevir/ritonavir with or without dasabuvir in adult genotype 1a or genotype 4 hepatitis C infected participants with severe kidney impairment or end-stage kidney disease.</brief_summary>
	<brief_title>Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<criteria>Chronic hepatitis C, genotype 1a infection or genotype 4 infection (HCV RNA level greater than 1,000 IU/mL at Screening). Females must be postmenopausal, of nonchild bearing potential or practicing specific forms of birth control. Chronic kidney disease stage 4 or stage 5. Females who are pregnant or breastfeeding Positive screen for hepatitis B Surface antigen or antiHuman Immunodeficiency virus antibody HCV genotype performed during screening unable to genotype or coinfection with any other HCV genotype, no mixed genotypes. Abnormal laboratory tests Current enrollment in another investigational study Prior treatment with a direct acting antiviral agent (DAA) containing regimen with the exception of interferon or pegylated interferon with or without ribavirin Current treatment with a direct acting antiviral agent (DAA) containing regimen Any evidence of liver cirrhosis or liver cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>hepatitis C infection</keyword>
	<keyword>interferon</keyword>
	<keyword>hepatitis C</keyword>
	<keyword>treatment experienced</keyword>
	<keyword>severe kidney disease</keyword>
	<keyword>Chronic Kidney Disease</keyword>
</DOC>